The combination of anti-PD-1 (7mg/kg) and Alphataxin (10 mg/kg) decreased tumor growth or induced tumor regression of the implanted renal adenocarcinoma cells suggesting these doses and treatment schedule are sufficiently efficacious. Here, PDCD1 is linked to neoplasm.